{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:00:28Z","timestamp":1791896428155,"version":"4.3.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-10-1-0499"],"award-info":[{"award-number":["W81XWH-10-1-0499"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.urolonc.2012.07.008","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T04:13:14Z","timestamp":1348632794000},"page":"735-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence"],"prefix":"10.1016","volume":"30","author":[{"given":"Brandon L.","family":"Pierce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2012.07.008_bib1","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/dc06-0062","article-title":"Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National health and nutrition examination survey 1999\u20132002","volume":"29","author":"Cowie","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.urolonc.2012.07.008_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2337\/dc08-1296","article-title":"Full accounting of diabetes and pre-diabetes in the U.S. population in 1988 1994 and 2005\u20132006","volume":"32","author":"Cowie","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.urolonc.2012.07.008_bib3","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.2337\/diacare.27.12.2806","article-title":"Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S","volume":"27","author":"Gregg","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.urolonc.2012.07.008_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1370\/afm.214","article-title":"Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988\u20132000","volume":"3","author":"Koopman","year":"2005","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.urolonc.2012.07.008_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0029-1243193","article-title":"Diabetes mellitus type 2 - An independent risk factor for cancer?","volume":"118","author":"Grote","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.urolonc.2012.07.008_bib6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.urolonc.2012.07.008_bib7","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1158\/1055-9965.EPI-06-0410","article-title":"A meta-analysis of diabetes mellitus and the risk of prostate cancer","volume":"15","author":"Kasper","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib8","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-004-1415-6","article-title":"Diabetes mellitus and risk of prostate cancer: A meta-analysis","volume":"47","author":"Bonovas","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.urolonc.2012.07.008_bib9","first-page":"493","article-title":"History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP diet and health study","volume":"18","author":"Calton","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2012.07.008_bib10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/ijc.24044","article-title":"Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study","volume":"124","author":"Kasper","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.07.008_bib11","first-page":"1267","article-title":"Diabetes mellitus and prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"19","author":"Leitzmann","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2012.07.008_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/aje\/kwp003","article-title":"Association of diabetes with prostate cancer risk in the multiethnic cohort","volume":"169","author":"Waters","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/sj.pcan.4500914","article-title":"Diabetes and the risk of prostate cancer: The role of diabetes treatment and complications","volume":"10","author":"Velicer","year":"2007","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2012.07.008_bib14","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1158\/1055-9965.EPI-06-0477","article-title":"Obesity, diabetes, and risk of prostate cancer: Results from the prostate cancer prevention trial","volume":"15","author":"Gong","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ijc.25360","article-title":"Association of diabetes mellitus with prostate cancer: Nested case-control study (prostate testing for cancer and treatment study)","volume":"128","author":"Turner","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.07.008_bib16","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/pros.21023","article-title":"The protective effect of diabetes mellitus against prostate cancer: Role of sex hormones","volume":"69","author":"Baradaran","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2012.07.008_bib17","first-page":"422","article-title":"The risk factors of prostate cancer: A multicentric case-control study in Iran","volume":"8","author":"Pourmand","year":"2007","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib18","first-page":"879","article-title":"Diabetes and risk of incident cancer: A large population-based cohort study in Israel","volume":"21","author":"Chodick","year":"2010","journal-title":"Cancer Causes Control Jun"},{"key":"10.1016\/j.urolonc.2012.07.008_bib19","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/pros.20777","article-title":"Diabetes mellitus and prostate cancer risk","volume":"68","author":"Pierce","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2012.07.008_bib20","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/sj.bjc.6605077","article-title":"A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk","volume":"100","author":"Wallstr\u00f6m","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2012.07.008_bib21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.annepidem.2011.07.007","article-title":"The metabolic syndrome and risk of prostate cancer in Italy","volume":"21","author":"Pelucchi","year":"2011","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib22","first-page":"1025","article-title":"History of diabetes mellitus and the risk of prostate cancer: The Ohsaki cohort study","volume":"21","author":"Li","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2012.07.008_bib23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2337\/dc10-1640","article-title":"Diabetes and risk of prostate cancer: A study using the national health insurance","volume":"34","author":"Tseng","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.urolonc.2012.07.008_bib24","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/ijc.21600","article-title":"Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada","volume":"118","author":"Rousseau","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.07.008_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ijc.10685","article-title":"Reduced risk of prostate cancer among patients with diabetes mellitus","volume":"102","author":"Weiderpass","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.07.008_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.eururo.2004.10.027","article-title":"Diabetes mellitus and the risk of prostate cancer in Italy","volume":"47","author":"Tavani","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00008469-200204000-00003","article-title":"Diabetes and the risk of prostate cancer","volume":"11","author":"Tavani","year":"2002","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib28","first-page":"3","article-title":"Diabetes mellitus and risk of prostate cancer (United States)","volume":"9","author":"Giovannucci","year":"1998","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2012.07.008_bib29","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/aje\/kwh139","article-title":"History of diabetes mellitus and risk of prostate cancer in physicians","volume":"159","author":"Zhu","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/aje\/kwh334","article-title":"Diabetes and risk of prostate cancer in a prospective cohort of US men","volume":"161","author":"Rodriguez","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pcd.2011.10.004","article-title":"The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: An observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes","volume":"6","author":"Lind","year":"2012","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.urolonc.2012.07.008_bib32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1158\/1055-9965.EPI-07-2610","article-title":"Glycemic status and risk of prostate cancer","volume":"17","author":"Darbinian","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000289594","article-title":"Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk","volume":"69","author":"Pierce","year":"2010","journal-title":"Hum Hered"},{"key":"10.1016\/j.urolonc.2012.07.008_bib34","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1158\/1055-9965.EPI-11-0019","article-title":"No association of type 2 diabetes risk variants and prostate cancer risk: The multiethnic cohort and PAGE","volume":"20","author":"Waters","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pros.21094","article-title":"HNF1B and JAZF1 genes, diabetes, and prostate cancer risk","volume":"70","author":"Stevens","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2012.07.008_bib36","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2337\/dc07-1962","article-title":"Serum prostate-specific antigen levels in men with type 2 diabetes","volume":"31","author":"Fukui","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.urolonc.2012.07.008_bib37","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1158\/1055-9965.EPI-08-0794","article-title":"Association of diabetes and Body Mass Index with levels of prostate-specific antigen: Implications for correction of prostate-specific antigen cutoff values?","volume":"18","author":"Muller","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib38","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/aje\/kwj311","article-title":"Prostate-specific antigen values in diabetic and nondiabetic US men, 2001\u20132002","volume":"164","author":"Werny","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib39","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/dc07-1148","article-title":"Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men","volume":"31","author":"Sarma","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.urolonc.2012.07.008_bib40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/pcan.2011.28","article-title":"Diabetes and prostate cancer risk in the REDUCE trial","volume":"14","author":"Wu","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2012.07.008_bib41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/ncpuro0944","article-title":"The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer","volume":"4","author":"Skolarus","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/epirev\/mxm006","article-title":"Obesity and prostate cancer: Making sense out of apparently conflicting data","volume":"29","author":"Freedland","year":"2007","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib43","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/annonc\/mdr603","article-title":"Body mass index and incidence of localized and advanced prostate cancer\u2014a dose\u2013response meta-analysis of prospective studies","volume":"23","author":"Discacciati","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib44","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.urolonc.2009.12.011","article-title":"Influence of obesity on the incidence and treatment of genitourinary malignancies","volume":"29","author":"Stewart","year":"2011","journal-title":"Urol Oncol"},{"issue":"6 Suppl","key":"10.1016\/j.urolonc.2012.07.008_bib45","first-page":"S32","article-title":"Diabetes and benign prostatic hyperplasia\/lower urinary tract symptoms\u2014what do we know?","volume":"182","author":"Sarma","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib46","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3346\/jkms.2011.26.9.1214","article-title":"Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels","volume":"26","author":"Kim","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.urolonc.2012.07.008_bib47","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0090-4295(99)80353-7","article-title":"The influence of prostate size on cancer detection","volume":"46","author":"Uzzo","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.07.008_bib48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0090-4295(00)00993-6","article-title":"Prostate-specific antigen best practice policy\u2014part I: Early detection and diagnosis of prostate cancer","volume":"57","author":"Carroll","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.07.008_bib49","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/aje\/kwq493","article-title":"Association of symptomatic benign prostatic hyperplasia and prostate cancer: Results from the prostate cancer prevention trial","volume":"173","author":"Schenk","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib50","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000478-198808000-00003","article-title":"Normal histology of the prostate","volume":"12","author":"McNeal","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/pcan.2011.40","article-title":"The association of diabetes and positive prostate biopsy in a US veteran population","volume":"15","author":"Moses","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2012.07.008_bib52","first-page":"977","article-title":"The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series","volume":"22","author":"Moreira","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2012.07.008_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/pros.21405","article-title":"Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi ((\u226512)-core prostate biopsy","volume":"72","author":"Hong","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2012.07.008_bib54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1055-9965.EPI-09-0777","article-title":"Diabetes and outcomes after radical prostatectomy: Are results affected by obesity and race?","volume":"19","author":"Jayachandran","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/pcan.2010.41","article-title":"Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?","volume":"14","author":"Abdollah","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2012.07.008_bib56","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/j.ijrobp.2011.07.003","article-title":"Type of Diabetes Mellitus and the odds of Gleason score 8 to 10 prostate cancer","volume":"82","author":"Kang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2012.07.008_bib57","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.juro.2011.07.072","article-title":"Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy","volume":"186","author":"Mitin","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1749-6632.2011.06285.x","article-title":"Diabetes, cancer, and metformin: Connections of metabolism and cell proliferation","volume":"1243","author":"Gallagher","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.urolonc.2012.07.008_bib59","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: A systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.urolonc.2012.07.008_bib60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1055-9965.EPI-10-0940","article-title":"Metformin and the incidence of prostate cancer in patients with type 2 diabetes","volume":"20","author":"Azoulay","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1677\/erc.1.01182","article-title":"Beyond peroxisome proliferator-activated receptor gamma signaling: The multi-facets of the antitumor effect of thiazolidinediones","volume":"13","author":"Weng","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.urolonc.2012.07.008_bib62","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2006.07.2777","article-title":"Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes","volume":"25","author":"Govindarajan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib63","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/pds.1352","article-title":"Cancer risks in thiazolidinedione users compared to other anti-diabetic agents","volume":"16","author":"Koro","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.urolonc.2012.07.008_bib64","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1158\/1055-9965.EPI-09-0215","article-title":"Use of thiazolidinediones does not affect prostate-specific antigen levels in men with diabetes","volume":"18","author":"Pini","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib65","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2337\/dc10-1067","article-title":"Cohort study of pioglitazone and cancer incidence in patients with diabetes","volume":"34","author":"Ferrara","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.urolonc.2012.07.008_bib66","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/aje\/kwn190","article-title":"Antidiabetic medication and prostate cancer risk: A population-based case-control study","volume":"168","author":"Murtola","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib67","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1053\/j.gastro.2007.03.050","article-title":"The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas","volume":"132","author":"Giovannucci","year":"2007","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"10.1016\/j.urolonc.2012.07.008_bib68","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.S16","article-title":"Five stages of evolving beta-cell dysfunction during progression to diabetes","volume":"53","author":"Weir","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.urolonc.2012.07.008_bib69","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/ijc.22587","article-title":"Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden","volume":"120","author":"Stocks","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.07.008_bib70","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1940-6207.CAPR-09-0188","article-title":"Finasteride modifies the relation between serum C-peptide and prostate cancer risk: Results from the prostate cancer prevention trial","volume":"3","author":"Neuhouser","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.urolonc.2012.07.008_bib71","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1158\/1940-6207.CAPR-10-0053","article-title":"Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study","volume":"3","author":"Lai","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.urolonc.2012.07.008_bib72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.pcan.4500924","article-title":"The association between body size, prostate volume and prostate-specific antigen","volume":"10","author":"Fowke","year":"2007","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2012.07.008_bib73","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/jnci\/djp260","article-title":"Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer","volume":"101","author":"Albanes","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2012.07.008_bib74","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1158\/1055-9965.EPI-07-0495","article-title":"Prediagnostic C-peptide and risk of prostate cancer","volume":"16","author":"Borugian","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.urology.2003.09.060","article-title":"Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging","volume":"63","author":"Hubbard","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.07.008_bib76","article-title":"Glycated hemoglobin and cancer incidence and mortality in the atherosclerosis in communities (ARIC) study, 1990\u20132006","author":"Joshu","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2012.07.008_bib77","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1210\/jc.2004-2190","article-title":"Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men","volume":"90","author":"Pitteloud","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urolonc.2012.07.008_bib78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djm323","article-title":"Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies","volume":"100","author":"Roddam","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2012.07.008_bib79","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1158\/1055-9965.EPI-08-0448","article-title":"Androgen and prostate cancer: Is the hypothesis dead?","volume":"17","author":"Hsing","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2012.07.008_bib80","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ajhb.21016","article-title":"Population differences in the testosterone levels of young men are associated with prostate cancer disparities in older men","volume":"22","author":"Calistro Alvarado","year":"2010","journal-title":"Am J Hum Biol"},{"key":"10.1016\/j.urolonc.2012.07.008_bib81","first-page":"703","article-title":"Hormonal profile of diabetic men and the potential link to prostate cancer","volume":"19","author":"Kasper","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2012.07.008_bib82","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diacare.27.5.1036","article-title":"Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men","volume":"27","author":"Laaksonen","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.urolonc.2012.07.008_bib83","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/beem.2002.0212","article-title":"IGFs and IGFBPs: Role in health and disease","volume":"16","author":"Monzavi","year":"2002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.urolonc.2012.07.008_bib84","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-149-7-200810070-00006","article-title":"Insulin-like growth factors, their binding proteins, and prostate cancer risk: Analysis of individual patient data from 12 prospective studies","volume":"149","author":"Roddam","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2012.07.008_bib85","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.mehy.2009.09.042","article-title":"Why does diabetes offer protective effects against prostate cancer?","volume":"74","author":"Zhang","year":"2010","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.urolonc.2012.07.008_bib86","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mehy.2010.02.019","article-title":"Are microvascular complications of diabetes mellitus really associated with prostate cancer?","volume":"75","author":"Beyazit","year":"2010","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.urolonc.2012.07.008_bib87","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/pcan.2009.39","article-title":"Does pre-existing diabetes affect prostate cancer prognosis?","volume":"13","author":"Snyder","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912002505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912002505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:52:40Z","timestamp":1786132360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143912002505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1078143912002505"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.07.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}